6 Dimensions Capital, L.P. 4
4 · Fulcrum Therapeutics, Inc. · Filed Jul 22, 2019
Insider Transaction Report
Form 4
6 Dimensions Capital, L.P.
10% Owner
Transactions
- Conversion
Common Stock
2019-07-22+441,071→ 441,071 total - Purchase
Common Stock
2019-07-22$16.00/sh+118,750$1,900,000→ 559,821 total - Conversion
Series B Preferred Stock
2019-07-22−3,087,500→ 0 total→ Common Stock (441,071 underlying)
Footnotes (1)
- [F1]On July 22, 2019 the Series B Preferred Stock converted into Common Stock on 7:1 basis upon the closing of the issuer's initial public offering without payment of consideration. The shares had no expiration date.